Islamabad, November 18, 2026: The Drug Regulatory Authority of Pakistan (DRAP) has finalised regulations and quality control parameters to bring the manufacturing, registration and sale of alternative medicines under a formal regulatory framework.
In this regard, DRAP has also issued an official memorandum outlining the new requirements.
According to the memorandum, vitamins, multivitamins and food supplements have also been brought under the regulatory framework, making their registration and licensing mandatory. The move aims to bring the manufacturing and sale of alternative medicines and related products within a proper legal framework.
DRAP has set a six-month deadline for obtaining manufacturing licences for alternative medicines, while manufacturers have been given 18 months to complete the registration process. All establishments involved in the manufacturing and sale of traditional medicines, including homeopathic products, will be required to comply with the prescribed rules and regulations.
The memorandum states that approximately 600 manufacturing units are currently producing alternative medicines in Pakistan, while around 1,000 importers are engaged in the business of importing such products.
Under the new regulatory framework, manufacturers and importers will be required to fulfil the prescribed requirements for the manufacturing, import, registration and sale of alternative medicines, vitamins, multivitamins and food supplements.





